Skip to main content
Xvivo Perfusion logo

Xvivo Perfusion — Investor Relations & Filings

Ticker · XVIVO ISIN · SE0004840718 LEI · 549300G2464FYLS14B41 ST Manufacturing
Open in API
Filings indexed 286 across all filing types
Latest filing 2022-09-21 Regulatory Filings
Country SE Sweden
Listing ST XVIVO

About Xvivo Perfusion

https://www.xvivogroup.com/

Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.

Recent filings

Filing Released Lang Actions
XVIVO presenterar strategi för 2023-2027 på kapitalmarknadsdagen
Regulatory Filings Classification · 99% confidence The document is an announcement titled "XVIVO presenterar strategi för 2023-2027 på kapitalmarknadsdagen" (XVIVO presents strategy for 2023-2027 at the Capital Markets Day). It details the company's strategy, financial targets (EBIT/EBITDA margins), and management updates, all presented during a scheduled Capital Markets Day event. This content strongly aligns with an Investor Presentation (IP), which typically covers strategy, financials, and outlook presented to investors. Although it announces an event, the core content provided is the substance of the presentation itself, not just a brief notice of publication. Given the detailed strategic and financial outlook, 'Investor Presentation' (IP) is the most appropriate classification over a generic 'Report Publication Announcement' (RPA).
2022-09-21 Swedish
XVIVO presents strategy for 2023-2027 at its Capital Markets Day
Investor Presentation Classification · 98% confidence The document explicitly states in the title and body that the company (XVIVO) is presenting its strategy for 2023-2027 at its 'Capital Markets Day'. A Capital Markets Day (CMD) is an event where management presents detailed strategy, financial targets, and outlook to investors. This aligns perfectly with the definition of an Investor Presentation (IP), which typically covers strategy and financials in detail, often presented during such events. Although it is an announcement of the event, the content provided is the substance of the presentation itself (strategy, financial targets, management changes), making 'IP' a stronger fit than a generic 'RPA' or 'RNS'. The document length (3083 chars) is substantial enough to contain the core presentation material, not just a brief notice to download a separate report.
2022-09-21 English
XVIVO enters into an agreement to acquire its Italian distributor - securing a unique business model
M&A Activity Classification · 99% confidence The document details an agreement for XVIVO Perfusion AB to acquire its Italian distributor, Avionord M&P. This involves purchase price, share issuance, earn-out payments, and strategic rationale. This type of corporate action—a merger or acquisition proposal/agreement—is explicitly covered by the 'M&A Activity' definition. The document is a detailed press release announcing the transaction, not a short announcement pointing to an attached report (which would suggest RPA or RNS). Therefore, the most specific classification is TAR (M&A Activity). The final line mentions the information is submitted for publication pursuant to the EU Market Abuse Regulation, which often accompanies significant corporate events like M&A.
2022-08-01 English
XVIVO ingår avtal om att förvärva sin italienska distributör - säkrar en unik affärsmodell
M&A Activity Classification · 99% confidence The document describes a definitive agreement for XVIVO Perfusion AB to acquire 100% of the shares in its Italian distributor's machine and perfusion business (Avionord M&P). It details the purchase price, payment structure (cash and newly issued shares), expected closing date (November 2022), financial background of the target, and transaction costs. The final line explicitly states: "Denna information är sådan information som XVIVO Perfusion AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that XVIVO Perfusion AB is obliged to disclose pursuant to the EU's Market Abuse Regulation.) This context strongly suggests a mandatory regulatory disclosure regarding a significant corporate event (M&A). Since the document is a detailed announcement of a major transaction (acquisition/takeover bid), the most appropriate category is M&A Activity (TAR). It is not a general Earnings Release (ER), a full Annual Report (10-K), or a simple dividend notice (DIV). It is a specific corporate action announcement.
2022-08-01 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport januari – juni 2022' (Interim Report January – June 2022) for XVIVO Perfusion AB. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management commentary on business performance for the specified period. It is a full interim report, not an announcement or a summary, and thus fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-07-13 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January – June 2022' and contains comprehensive financial statements, including income statements, cash flow data, and management commentary for the specified period. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-07-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.